Delivery Order SPE2DB20D7066-SPE2DB24FC1NQ

Award Date 11/20/23
Potential Completion Date 11/21/23
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Humira(CF) Pen 40 mg/0.4 mls pharmaceutical product to the Defense Logistics Agency (DLA). The $2,770.74 firm fixed price delivery order has a completion date of July 11, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The $1,790.51 fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of July 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,770.74 firm-fixed-price delivery order is for the supply of HUMIRA (CF) PEN 40 MG/0.4 ML, a pharmaceutical product, with a completion date of July 11, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,146.11 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The $6,288.06 Firm Fixed Price Delivery Order is for the supply of HUMIRA PEN 40 MG/0.8 MLS to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 20, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $6,036.68 firm-fixed-price delivery order is for the provision of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical is valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
The federal contract award, valued at $2,559.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Humira(CF) Pen 40 mg/0.4 mls pharmaceutical products. This is a firm fixed-price delivery order contract, with an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp is also the holder of a larger Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, valued at $3,694.32, is for the delivery of Humira Pen 40 mg/0.8 mls pharmaceutical products. The contract is a firm fixed price delivery order with a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA...
This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order valued at $10,754.36 for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical product. The contract, placed by the Defense Logistics Agency (DLA), has an ultimate completion date of August 7, 2024 and a firm fixed price pricing structure. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB24FC1NQ
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) for the delivery of Humira (CF) Pen 40 mg/0.4 mL pharmaceutical products. The $7,802.80 firm-fixed price delivery order has a completion date of November 21, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 7/19/24, 9:24 AM